RANDOMIZED PHASE-III TRIAL OF VINBLASTINE, BLEOMYCIN, AND CIS-DICHLORODIAMMINE-PLATINUM VERSUS DACARBAZINE IN MALIGNANT-MELANOMA

被引：90

作者：

LUIKART, SD

KENNEALEY, GT

KIRKWOOD, JM

机构：

[1] YALE UNIV,SCH MED,MELANOMA UNIT,NEW HAVEN,CT 06510

[2] YALE UNIV,SCH MED,DEPT INTERNAL MED,NEW HAVEN,CT 06510

[3] YALE UNIV,SCH MED,DEPT DERMATOL,NEW HAVEN,CT 06510

来源：

关键词：

D O I：

10.1200/JCO.1984.2.3.164

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：164 / 168

页数：5

共 18 条

[1] ABELE R, 1981, CANCER TREAT REP, V65, P505
[2] BAIRD GM, 1978, LANCET, V2, P681
[3] BAJETTA E, 1982, CANCER TREAT REP, V66, P1299
[4] CARTER RD, 1976, CANCER TREAT REP, V60, P601
[5] COMIS RL, 1976, CANCER TREAT REP, V60, P165
[6] COSTANZI JJ, 1982, P AM SOC CLIN ONCOL, V1, P169
[7] CREAGAN ET, 1981, CANC TREAT REP, V66, P567
[8] KORIECH O, 1980, P AM ASSOC CANC RES, V21, P168
[9] DACARBAZINE (DTIC) IN MALIGNANT-MELANOMA - REDUCED TOXICITY WITH PROTECTION FROM LIGHT
KORIECH, OM
SHUKLA, VS
[J]. CLINICAL RADIOLOGY, 1981, 32 (01) : 53 - 55
[10] LOO TL, 1976, CANCER TREAT REP, V60, P149